Fourth edition of radiotherapy dose fractionation guidance launched

We’re pleased to announce the launch of the fourth edition of the Radiotherapy dose fractionation guidance.

Originally published in 2006, this comprehensive document is widely recognised as one of the most important clinical oncology publications ever produced by the RCR. The third edition was one of the most popular downloaded publications in the last year.

Compiled by a team of highly experienced clinical oncologists, the fourth edition incorporates changes based on evidence published since the last update in 2019. It provides a concise summary of evidence-based radiotherapy fractionation schedules for all anatomical sites, to ensure its continuing role as a key reference document for all practicing clinical oncologists.

Dr Nicky Thorp, Medical Director, Professional Practice, Clinical Oncology, said: “I’m delighted we’ve published the fourth edition for what remains one of the most significant clinical oncology publications produced by the RCR to date.

“The review of this guidance continues to be led by Prof Peter Hoskins – and we thank him for his immense contribution and all his hard work as the lead editor. We also acknowledge the substantial contributions of our chapter leads in reviewing and updating this edition.”

This fourth edition supersedes the previous third edition, which has now been withdrawn.